Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Glioblastoma × Lomustine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 20 INDUSTRY 18 NIH 3 NETWORK 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 3 Temozolomide 2 pembrolizumab 1 ipatasertib 1 dactolisib 1 Zinc 1 Metformin 1 Lomustine 1 Hypoglycemic Agents 1 Duloxetine Hydrochloride 1 Diet, Carbohydrate-Restricted 1 Biguanides 1 Atorvastatin 1 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06419946 2024-11-19

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Vastra Gotaland Region

Phase 3 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡